about
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating man...
Read More
5.17
-0.04
(-0.77%)
40,542
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Polypid Ltd is on 29 Sep 2026 for the purpose of Lytham Partners Fall 2026 Investor Conference
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Polypid Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..